Yahoo
    HKSE - Delayed Quote HKD

    Lepu Biopharma Co., Ltd. (2157.HK)

    3.155 +0.090 (+2.94%)
    At close: October 30 at 4:08:06 PM GMT+8
    Loading Chart for 2157.HK
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Lepu Biopharma (SEHK:2157) Rebounds In The Short Term While Valuation Stays In Focus

    Lepu Biopharma (SEHK:2157) Rebounds In The Short Term While Valuation Stays In Focus
    Simply Wall St. 3mo ago
    ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026

    ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
    GlobeNewswire 7d ago
    AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales

    AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales
    GuruFocus.com 3mo ago
    BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC

    BioDlink and Lepu Biopharma Celebrate Successful Launch of the World's First EGFR-Targeting ADC Drug, Marking a Major Milestone in Mutual Collaboration in Biologics CMC
    PR Newswire 11mo ago
    BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC

    BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
    PR Newswire 11mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: